Skip to main content
. 2018 Feb 22;56(3):e01633-17. doi: 10.1128/JCM.01633-17

TABLE 1.

Activity of beta-lactams for 308 P. aeruginosa evaluated in this study, as determined by rBMD

Beta-lactama No. (%) of isolates
Susceptible Resistant
Ceftazidime 76 (24.6) 209 (67.6)
Cefepime 80 (25.9) 149 (48.2)
Imipenem 37 (12.0) 259 (83.8)
Meropenem 49 (15.9) 228 (73.8)
TZP 64 (20.7) 183 (59.2)
C-T 224 (72.5) 66 (21.4)
a

C-T, ceftolozane-tazobactam; TZP, piperacillin-tazobactam.